10.25.2022
Therapeutics
$1,702,077.00
36 months
Targeted, sustained release antifibrotic therapies for Crohn's disease patients
This project aims to develop an anti-fibrotic pipeline that will result in small molecule products that will change the standard of care and improve outcomes for patients with stricturing Crohn's disease.